Please login to the form below

Not currently logged in
Email:
Password:

Amgen appoints senior VP and head of the European region

Corinne Le Goff assumed the role on June 1

edit-corinne-le-goffAmgen has named Corinne Le Goff as senior vice president and head of the European region.

Effective from June 1, Le Goff will be responsible for leading Amgen's growth in Europe and will report directly to executive VP of global commercial operations, Anthony Hooper.

Commenting on her appointment, Le Goff said: “This is a pivotal moment for Amgen with a number of innovative new compounds either in the late stage clinical research or under review by the European regulatory authorities. 

“I am delighted to have the opportunity to lead the team in Europe at this exciting time.”

Le Goff joins from Roche, where she most recently served as president since 2012. In the role, she successfully led the business and a team of over 1,200 staff and helped evolve the business into one with a greater focus on market access and key account management.

Previously, Le Goff spent five years in strategic commercial leadership roles managing therapeutic areas at Roche, where she was senior VP of global product strategy for the neurosciences franchise and at Merck Serono, where she was senior VP of strategy and global marketing for neurology, rheumatology and immunology.

Hooper added: “Corinne brings strong vision and leadership to our European operations based on her broad strategic and operational experience in large healthcare organisations at both the global and affiliate level. I am delighted to welcome her to the team”.

15th June 2015

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics